Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease

medcases00
Published on Jul 23, 2021
Video Embed Original Content source - Glomerular Disease Study & Trial Consortium
https://www.youtube.com/channel/UC7FG1vWfVQSwOcJHO35lOAg

Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease

Chair, Jay B. Wish, MD, discusses advances in the management of anemia in chronic kidney disease in this CME/MOC/NCPD/CPE activity titled “Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease: Examining the Current State of the Science.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/UNQ865. CME/MOC/NCPD/CPE credit will be available until March 25, 2022.